Trial Profile
Safety and efficacy of Plerixafor for mobilisation of autologus peripheral blood stem cells in pediatric patients with relapsed malignancies
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary)
- Indications Stem cell mobilisation
- Focus Adverse reactions; Therapeutic Use
- 10 Jul 2017 New trial record